SE Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 3 more risks
Sweet Earth Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.85 |
| 52 Week Low | CA$0.01 |
| Beta | 2.42 |
| 11 Month Change | 0% |
| 3 Month Change | -28.57% |
| 1 Year Change | n/a |
| 33 Year Change | -98.86% |
| 5 Year Change | n/a |
| Change since IPO | -99.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| SE | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -5.2% | 1.3% |
| 1Y | n/a | -23.4% | 23.1% |
Return vs Industry: Insufficient data to determine how SE performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how SE performed against the Canadian Market.
Price Volatility
| SE volatility | |
|---|---|
| SE Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: SE's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine SE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Robert Dubeau | sweetearthskincare.com |
Sweet Earth Holdings Corporation does not have significant operations. Previously, it was engaged in cultivating, processing, and selling hemp cannabidiol (CBD) products The company is based in Vancouver, Canada.
Sweet Earth Holdings Corporation Fundamentals Summary
| SE fundamental statistics | |
|---|---|
| Market cap | CA$620.07k |
| Earnings (TTM) | CA$182.92k |
| Revenue (TTM) | CA$9.67k |
3.4x
P/E Ratio64.1x
P/S RatioIs SE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SE income statement (TTM) | |
|---|---|
| Revenue | CA$9.67k |
| Cost of Revenue | CA$4.10k |
| Gross Profit | CA$5.58k |
| Other Expenses | -CA$177.35k |
| Earnings | CA$182.92k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0074 |
| Gross Margin | 57.66% |
| Net Profit Margin | 1,891.45% |
| Debt/Equity Ratio | -17.5% |
How did SE perform over the long term?
See historical performance and comparison